Expression of alpha-fetoprotein messenger RNA in BEL-7404 human hepatoma cells and effect of L-4-oxalysine on the expression

World Journal of Gastroenterology

Volumn 4, Issue 1-6, 1998, Pages 294-297

  Wang, Xing Wang ^a,b,c   Xu, Bin ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Fetoprotein; Gene expression; Immunohistochemistry; In situ hybridization; Liver neoplasms; Oxalysine; RNA, messenger; Tumor cell, cultured

Indexed keywords

EID: 0001619629     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v4.i4.294     Document Type: Article

References (20)

1. Wang XW, Xu B. Effect of alpha-fetoprotein on the growth of mouse ascites hepatoma-22 cells in vitro. Acta Oncol Sin, 1995;5(4):229-231
2. Wang XW, Xu B. Influence of alpha-fetoprotein on the growth of tumor cells in vitro. Chin J Cancer Res, 1997;9(2):79-82
3. Wang XW, Xu B. Effect of alpha-fetoprotein (AFP) on splenocyte proliferation of mice bearing ascites hepatoma-22 in vitro. Shanghai J Immunol, 1995;15(6): 327-329
4. Wang XW, Xu B. Effect of human alpha-fetoprotein on immunological functions in mice bearing ascites hepatoma-22 in vitro. Shanghai J Immunol, 1997;17 (4):224-226
5. Wang XW, Xu B. Effect of some drugs on alpha-fetoprotein and treatment of primary hepatocellular carcinoma. Chin Oncol, 1995;4(12):24-26
6. Wang XW, Xu B. Several new targets of antitumor agents. Acta Pharmacol Sin, 1997;18(4):289-292
7. Wang XW, Xu B. Alpha-fetoprotein, primary hepatocellular carcinoma and anticancer drugs. In: Cao SR, ed. New theory and technology of oncology. Shanghai: Shanghai Science and Technology Education Press, 1997:485-497
8. Wang XW, Xu B. L-4-oxalysine, a new antitumor agent of natural origin. Med Chem Res, 1996;6(4):225-232
9. Wang XW, Xu B. Mechanisms of antitumor action of L-4-oxalysine, a new natural product. Med Chem Res, 1996;6(4):233-247
10. Wang XW, Xu B. Antitumor and immunological activities of oxalysine. Chin J Oncol, 1997;19(2):115-117
11. Wang XW, Xu B. Immunoregulatory activity of L-4-oxalysine: an in vitro study. Meth Find Exp Clin Pharmacol, 1997;19(7):437-442
12. Wang XW, Xu B. L-4-oxalysine: Its antitumor activities and mechanisms of action. Drugs Fut, 1996;21(7):727-731
13. Wang XW, Xu B. Anti-alpha-fetoprotein activity of L-4-oxalysine. Asia Pacific J Pharmacol, 1996;11(2):25-28
14. Wang XW, Xu B. Effect of L-4-oxalysine on alpha-fetoprotein gene expression in human BEL-7404 hepatoma cells. Asia Pacific J Pharmacol, 1997;12(1-2): 37-40
15. Urano Y, Sakai M, Watanabe K, Tamaoki T. Tandem arrangement of the albumin and alpha-fetoprotein genes in human genome. Gene, 1984;32(11): 255-261
16. Morinage T, Sakai M, Wegmann TG, Tamaoki T. Primary structures of human alpha-fetoprotein and its mRNA. Proc Natl Acad Sci USA, 1983;80(8):4604-4608
17. Sambrook J, Fritsch EF, Mantiatis T. Molecular cloning: A laboratory mannual. New York: Cold Spring Hober Laboratory Press, 1989:304-316
18. Furuta Y, Shinohara T, Sano K, Meguro M, Nagashima K. In situ hybridization with digoxigenin-labelled DNA probes for detection of viral genomes. J Gin Pathol, 1990;43(3):806-809
19. Breborowicz J, Tamaoki T. Detection of messenger RNAs of alpha-fetoprotein and albumin in a human hepatoma cell line by in situ hybridization. Cancer Res, 1985;45(4):1730-1736
20. Wang XW, Xu B. Research advances of research of alpha-fetoprotein gene expression and the expression regulation. Acta Oncol Sin, 1996;6(4):281-284